The launch affirms commitment to Glenmark's continued focus on institutional business, company Senior Vice President, Business Development Portfolio, Product Launch & Strategy, Vijay Raghavan said. The Bumex injection, 0.25 mg/mL achieved annual sales of approximately USD 16.5 million, the company said citing IQVIA sales data for the 12-month period ended November 2022.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gpGR6Jx
via IFTTT
0 comments:
Post a Comment